Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
Related News and Success stories.
-
19 Dec 2024
Catalonia's Tech Hubs: Cultivating Talent and Driving Innovation in Europe
-
18 Dec 2024
Catalonia: A Global Example of Cluster Excellence
-
13 Dec 2024
YPlasma, best 2024 startup of Catalonia
-
11 Dec 2024
Barcelona will host one of the seven AI Innovation factories in Europe